Triglav Investments D.O.O. Sells 3,500 Shares of Intuitive Surgical, Inc. $ISRG

Triglav Investments D.O.O. trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 43.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,520 shares of the medical equipment provider’s stock after selling 3,500 shares during the quarter. Triglav Investments D.O.O.’s holdings in Intuitive Surgical were worth $2,021,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Brighton Jones LLC boosted its position in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares during the period. Sivia Capital Partners LLC raised its stake in shares of Intuitive Surgical by 3.8% during the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after acquiring an additional 34 shares during the last quarter. Canopy Partners LLC raised its stake in shares of Intuitive Surgical by 48.8% during the second quarter. Canopy Partners LLC now owns 1,222 shares of the medical equipment provider’s stock valued at $664,000 after acquiring an additional 401 shares during the last quarter. BankPlus Trust Department lifted its holdings in shares of Intuitive Surgical by 131.8% during the second quarter. BankPlus Trust Department now owns 153 shares of the medical equipment provider’s stock worth $83,000 after purchasing an additional 87 shares during the period. Finally, Venturi Wealth Management LLC grew its stake in shares of Intuitive Surgical by 4.6% in the second quarter. Venturi Wealth Management LLC now owns 1,795 shares of the medical equipment provider’s stock worth $975,000 after purchasing an additional 79 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Piper Sandler reaffirmed an “overweight” rating and set a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Evercore ISI reduced their target price on Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a report on Friday, January 23rd. Citigroup reissued a “neutral” rating and set a $590.00 target price (down previously from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Finally, Barclays set a $712.00 price target on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday, January 26th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $620.41.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 750 shares of the company’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $435,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 464 shares of Intuitive Surgical stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $548.49, for a total transaction of $254,499.36. Following the transaction, the senior vice president owned 131 shares of the company’s stock, valued at $71,852.19. This represents a 77.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 73,616 shares of company stock worth $40,929,575 in the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 0.1%

Shares of NASDAQ ISRG opened at $478.49 on Thursday. The firm’s 50-day moving average price is $553.29 and its 200-day moving average price is $510.97. The firm has a market capitalization of $171.53 billion, a P/E ratio of 60.65, a P/E/G ratio of 3.72 and a beta of 1.65. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the previous year, the company posted $2.21 earnings per share. The company’s quarterly revenue was up 18.8% on a year-over-year basis. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.